Wird geladen...
P15 COMPARATIVE OUTCOMES OF BEVACIZUMAB AND PCV CHEMOTHERAPY IN PATIENTS WITH RECURRENT AND PROGRESSIVE GLIOBLASTOMA: A RETROSPECTIVE STUDY
INTRODUCTION: Bevacizumab (Bev)is used in patients with recurrent high grade glioma in many countries; however, its efficacy has not been compared with a combination of procarbazine, lomustine and vincristine (PCV), a commonly used chemotherapy regimen in the UK. We present comparative outcomes in p...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Oxford University Press
2014
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4200891/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou249.14 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|